Half-year report · Q2
4820.TEDINET S100WI6Z
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥24.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥2.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.2bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.3bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥985m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥29.0bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥31.7bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥29.3bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.5bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥11.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.5bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.4bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.7bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.7bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥568m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥194m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥15m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.18 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.54 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥23.1 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.43 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥13.96 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.4% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.8% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.4% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥68m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥68m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | ¥21m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥262m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥262m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥169m |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥80m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥571m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥512m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥59m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥23m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥9m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.1bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥12.2bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥12.1bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥68m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.1bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥79m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥79m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | ¥32m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥283m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥283m |
| jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥229m |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥306m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥572m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥502m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥70m |
| jpcrp040300-q2r_E05155-000Other Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥40m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥9.0bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥9.0bn |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥9m |
| jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.7bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥11.1bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥11.0bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥79m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 519
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses sga | Prior1YTDDuration | 323000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 317000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 10000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 8000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9004000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1198000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 283000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 502000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 10989000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 10989000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 70000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 79000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -79000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9013000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1198000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 283000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 572000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 11069000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -79000000 | JPY |
| Net sales | Prior1YTDDuration | 10989000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1684000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | -306000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | -229000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 40000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1188000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 32000000 | JPY |
| Operating income | Prior1YTDDuration | 1221000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9876000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1497000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 262000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 512000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 12149000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 12149000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 59000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 68000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -68000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9885000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1497000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 262000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember | 571000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |